Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis-Reference-Cited by-同舟云学术

Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

Published:2019-07-31 Issue:7770 Volume:572 Page:538-542
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Wellenstein Max D.,Coffelt Seth B.,Duits Danique E. M.,van Miltenburg Martine H.,Slagter Maarten,de Rink Iris,Henneman Linda,Kas Sjors M.,Prekovic Stefan,Hau Cheei-Sing,Vrijland Kim,Drenth Anne Paulien,de Korte-Grimmerink Renske,Schut Eva,van der Heijden Ingrid,Zwart Wilbert,Wessels Lodewyk F. A.,Schumacher Ton N.,Jonkers Jos,de Visser Karin E.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-1450-6.pdf

Reference48 articles.

1. Diakos, C. I., Charles, K. A., McMillan, D. C. & Clarke, S. J. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 15, e493–e503 (2014).

2. McAllister, S. S. & Weinberg, R. A. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat. Cell Biol. 16, 717–727 (2014).

3. Templeton, A. J. et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl. Cancer Inst. 106, dju124 (2014).

4. Coffelt, S. B., Wellenstein, M. D. & de Visser, K. E. Neutrophils in cancer: neutral no more. Nat. Rev. Cancer 16, 431–446 (2016).

5. Coffelt, S. B. et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345–348 (2015).

Cited by 348 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locally advanced and metastatic endometrial cancer: Current and emerging therapies;Cancer Treatment Reviews;2024-09

2. The treatment landscape of triple-negative breast cancer;Medical Oncology;2024-08-29

3. GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model;Frontiers in Immunology;2024-08-19

4. Cracking the Codes behind Cancer Cells’ Immune Evasion;International Journal of Molecular Sciences;2024-08-15

5. Opportunities and Challenges in the Development of Antibody-Drug Conjugate for Triple-Negative Breast Cancer: The Diverse Choices and Changing Needs;World Journal of Oncology;2024-08